Africa In Vitro Diagnostics Market by Product & Services, Technology, Application, Diagnostic Approach, Customer Type

Africa In Vitro Diagnostics Market by Product & Services, Technology (Immunoassay, Point of Care, Molecular Diagnostics, Coagulation), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoC), Customer Type - Forecast to 2029

The Africa IVD market is expected to grow at a CAGR of 4.8% from 2022 to 2029 to reach $1.78 billion by 2029

Following a detailed secondary and primary research and an in-depth analysis of the market scenario, the report provides the key drivers, restraints, challenges, and opportunities in the Africa IVD market.

The high prevalence of infectious diseases, the rising burden of chronic diseases, the rising initiatives to support the healthcare sector, and the growing awareness about the importance of early disease diagnosis are the major drivers for the Africa IVD market. However, poor healthcare facilities and infrastructure in African countries are the major challenges to the market’s growth.

Based on product category, in 2022, the reagents, assays, and kits segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the frequent use of assays & kits in the detection of various chronic diseases coupled with the high burden of infectious diseases in African countries.

Based on technology, in 2022, the immunoassay segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the advantages of immunoassays, such as simplicity, high accuracy standards, high throughput capability, and inherent specificity.

Based on application, in 2022, the infectious diseases segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is primarily attributed to the high prevalence of infectious diseases such as COVID-19, dengue, HIV, and Chagas disease in the region and the rising initiatives to boost testing capabilities.

Based on diagnostic approach, in 2022, the laboratory testing segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the availability of several IVD tests and the higher accuracy offered by laboratory testing.

Based on customer type, in 2022, the hospital laboratories testing segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the high demand for IVD diagnostics and the higher preference for hospitals as the primary center of care.

Based on geography, in 2022, South Africa is expected to account for the largest share of this market. The major share of this region is mainly attributed to the high burden of diseases, the rising geriatric population, the increasing initiatives to promote diagnostic testing, and continuous efforts to develop healthcare infrastructure and promote awareness.

The key companies operating in the Africa IVD market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Illumina, Inc. (U.S.), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China).

Scope of the Report:

Africa IVD Market, by Product Category

Reagents, Assays, and Kits
Instruments
Software & Services

Africa IVD Market, by Technology

Immunoassay
Whole Blood Glucose Monitoring
Point-of-Care Diagnostics
Clinical Chemistry
Molecular Diagnostics
Hematology
Coagulation & Hemostasis
Critical Care
Urinalysis
Other IVD Technologies

Note: Other technologies include microscopy, hybridization, and loop-mediated amplification.

Africa IVD Market, by Application

Infectious Diseases
Diabetes
Oncology
Endocrinology
Cardiology
Other Applications

Note: Other applications include nephrology, toxicology, gastroenterology, neonatal, genetic, and neurological disorders.

Africa IVD Market, by Diagnostic Approach

Laboratory Testing
Point-of-Care Testing
OTC/Self-testing

Africa IVD Market, by Customer Type

Hospital Labs
Private Labs
Home Care/Self Testing
Government
Other Customer Types

Note: Other customer types include long-term care facilities, academic & research institutes, ambulatory care centers, and transfusion laboratories

Africa IVD Market, by Country

South Africa
Egypt
Nigeria
Kenya
Algeria
Tanzania
Morocco
Tunisia
Rest of Africa

1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study

3. Executive Summary

4. Market Dynamics
4.1. Market Overview
4.2. Drivers
4.2.1. Government Initiatives Supporting Africa’s Healthcare Sector
4.2.2. Rising Prevalence of Communicable and Noncommunicable Diseases
4.2.3. Key Market Players’ Increasing Investments in Africa’s IVD Sector
4.3. Restraints
4.3.1. High Prices of IVD Products
4.4. Opportunities
4.4.1. Increasing Awareness About the Importance of Early Diagnosis
4.5. Challenges
4.5.1. Uneven Access to Healthcare
4.5.2. Shortage of Trained Healthcare Personnel

5. Africa IVD Market, by Product Category
5.1. Introduction
5.2. Reagents, Assays, and Kits
5.3. Instruments
5.4. Software & Services

6. Africa IVD Market, by Technology
6.1. Introduction
6.2. Immunoassay
6.3. Whole Blood Glucose Monitoring
6.4. Point-of-Care Diagnostics
6.5. Clinical Chemistry
6.6. Molecular Diagnostics
6.7. Hematology
6.8. Coagulation & Hemostasis
6.9. Critical Care
6.10. Urinalysis
6.11. Other IVD Technologies

7. Africa IVD Market, by Application
7.1. Introduction
7.2. Infectious Diseases
7.3. Oncology
7.4. Diabetes
7.5. Endocrinology
7.6. Cardiology
7.7. Other Applications

8. Africa IVD Market, by Diagnostic Approach
8.1. Introduction
8.2. Laboratory Testing
8.3. Point-of-Care Testing
8.4. OTC/Self-Testing

9. Africa In Vitro Diagnostics Market, by Customer Type
9.1. Introduction
9.2. Hospital Labs
9.3. Private Labs
9.4. Home Care/Self-Testing
9.5. Government
9.6. Other Customer Types

10. Africa IVD Market, by Geography
10.1. Introduction
10.2. South Africa
10.3. Egypt
10.4. Nigeria
10.5. Kenya
10.6. Algeria
10.7. Tanzania
10.8. Morocco
10.9. Tunisia
10.10. Rest of Africa

11. Competitive Landscape
11.1. Introduction
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Market Share Analysis (2021)
11.4.1. F. Hoffmann-La Roche Ltd (Switzerland)
11.4.2. Abbott Laboratories (U.S.)
11.4.3. Danaher Corporation (U.S.)

12. Company Profiles (Business Overview, Financial Overview, Solutions Portfolio, Strategic Developments)
12.1. Abbott Laboratories
12.2. Becton, Dickinson and Company
12.3. bioMérieux SA
12.4. Danaher Corporation
12.5. F. Hoffmann-La Roche Ltd
12.6. QIAGEN N.V.
12.7. Siemens Healthineers AG (Subsidiary of Siemens AG)
12.8. Thermo Fisher Scientific Inc.
12.9. Bio-Rad Laboratories, Inc.
12.10. Illumina, Inc.
12.11. Shenzhen Mindray Bio-Medical Electronics Co., Ltd

13. Appendix
13.1. Questionnaire